Invention Grant
- Patent Title: Method for treating adenosine deaminase severe combined imunodeficiency
-
Application No.: US15383030Application Date: 2016-12-19
-
Publication No.: US10583180B2Publication Date: 2020-03-10
- Inventor: Adrian Thrasher , Donald Kohn , Bobby Gaspar
- Applicant: UCL Business PLC , The Regents of the University of California
- Applicant Address: GB London US CA Oakland
- Assignee: UCL Business LTD,The Regents of the University of California
- Current Assignee: UCL Business LTD,The Regents of the University of California
- Current Assignee Address: GB London US CA Oakland
- Agency: Clark & Elbing LLP
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A61K38/50 ; C07K14/47 ; A61K35/28 ; C12N7/00 ; C12N9/78 ; C12N15/86
Abstract:
The present invention relates to the prevention and/or treatment of ADA-SCID, in a patient.
Public/Granted literature
- US20170173124A1 TREATMENT Public/Granted day:2017-06-22
Information query
